Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with X
Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
---|---|---|---|---|---|---|---|
XANTHAN GUM | OPHTHALMIC | SOLUTION | 11138662 | TTV12P4NEE | 0.6%w/v | ||
XANTHAN GUM | OPHTHALMIC | SOLUTION, GEL FORMING, EXTENDED RELEASE | 11138662 | TTV12P4NEE | 0.6%w/w | ||
XANTHAN GUM | OPHTHALMIC | SUSPENSION | 11138662 | TTV12P4NEE | 0.6%w/w | ||
XANTHAN GUM | ORAL | CAPSULE | 11138662 | TTV12P4NEE | 0.01mg | ||
XANTHAN GUM | ORAL | CAPSULE, EXTENDED RELEASE | 11138662 | TTV12P4NEE | 0.16mg | ||
XANTHAN GUM | ORAL | FILM, SOLUBLE | 11138662 | TTV12P4NEE | 1mg | ||
XANTHAN GUM | ORAL | GRANULE, FOR SUSPENSION | 11138662 | TTV12P4NEE | 450mg | ||
XANTHAN GUM | ORAL | LIQUID, EXTENDED RELEASE | 11138662 | TTV12P4NEE | 50mg | ||
XANTHAN GUM | ORAL | LOZENGE | 11138662 | TTV12P4NEE | 1,264mg | ||
XANTHAN GUM | ORAL | PASTE | 11138662 | TTV12P4NEE | 1,050mg | Y | |
XANTHAN GUM | ORAL | POWDER | 11138662 | TTV12P4NEE | 275mg | ||
XANTHAN GUM | ORAL | POWDER, FOR SOLUTION | 11138662 | TTV12P4NEE | 10mg/5ml | ||
XANTHAN GUM | ORAL | POWDER, FOR SUSPENSION | 11138662 | TTV12P4NEE | 600mg | ||
XANTHAN GUM | ORAL | SOLUTION | 11138662 | TTV12P4NEE | 15mg | ||
XANTHAN GUM | ORAL | SUSPENSION | 11138662 | TTV12P4NEE | 150mg | ||
XANTHAN GUM | ORAL | SUSPENSION, EXTENDED RELEASE | 11138662 | TTV12P4NEE | 186.8mg | ||
XANTHAN GUM | ORAL | SUSPENSION/ DROPS | 11138662 | TTV12P4NEE | 2.9mg/1ml | ||
XANTHAN GUM | ORAL | TABLET | 11138662 | TTV12P4NEE | 56mg | ||
XANTHAN GUM | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 11138662 | TTV12P4NEE | 6mg | ||
XANTHAN GUM | ORAL | TABLET, EXTENDED RELEASE | 11138662 | TTV12P4NEE | 528mg | ||
XANTHAN GUM | ORAL | TABLET, FILM COATED | 11138662 | TTV12P4NEE | 0.08mg | ||
XANTHAN GUM | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 11138662 | TTV12P4NEE | 0.03mg | ||
XANTHAN GUM | ORAL | TABLET, ORALLY DISINTEGRATING | 11138662 | TTV12P4NEE | 0.15mg | ||
XANTHAN GUM | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 11138662 | TTV12P4NEE | 18mg | ||
XANTHAN GUM | ORAL | TROCHE | 11138662 | TTV12P4NEE | 184mg | ||
XANTHAN GUM | RECTAL | ENEMA | 11138662 | TTV12P4NEE | 0.25%w/v | ||
XANTHAN GUM | RECTAL | SUSPENSION | 11138662 | TTV12P4NEE | 0.06%w/v | ||
XANTHAN GUM | TOPICAL | AEROSOL, FOAM | 11138662 | TTV12P4NEE | 0.27%w/w | ||
XANTHAN GUM | TOPICAL | CREAM | 11138662 | TTV12P4NEE | 46mg | ||
XANTHAN GUM | TOPICAL | GEL | 11138662 | TTV12P4NEE | 2.85%w/w | ||
XANTHAN GUM | TOPICAL | LOTION | 11138662 | TTV12P4NEE | 0.3%w/v | ||
XANTHAN GUM | TOPICAL | SUSPENSION | 11138662 | TTV12P4NEE | 0.11%w/w | ||
XYLITOL | BUCCAL | GUM, CHEWING | 87990 | VCQ006KQ1E | 11,915mg | Y | |
XYLITOL | ORAL | FILM, SOLUBLE | 87990 | VCQ006KQ1E | 4.76mg | ||
XYLITOL | ORAL | PASTE | 87990 | VCQ006KQ1E | 180mg | Y | |
XYLITOL | ORAL | POWDER, FOR SUSPENSION | 87990 | VCQ006KQ1E | 4223mg | ||
XYLITOL | ORAL | SOLUTION | 87990 | VCQ006KQ1E | 21,600mg | ||
XYLITOL | ORAL | SUSPENSION | 87990 | VCQ006KQ1E | 1,500mg | ||
XYLITOL | ORAL | SUSPENSION, EXTENDED RELEASE | 87990 | VCQ006KQ1E | 9,000mg | ||
XYLITOL | ORAL | TABLET | 87990 | VCQ006KQ1E | 15.04mg | ||
XYLITOL | ORAL | TABLET, EXTENDED RELEASE | 87990 | VCQ006KQ1E | 2,752mg | ||
XYLITOL | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 87990 | VCQ006KQ1E | 72mg | ||
XYLITOL | ORAL | TABLET, ORALLY DISINTEGRATING | 87990 | VCQ006KQ1E | 360mg | ||
XYLITOL | SUBLINGUAL | SPRAY | 87990 | VCQ006KQ1E | 22mg |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 1, 2022
Database Last Updated: July 18, 2022